Clinical Trial Update: Near Normalisation of BG Improves the Potentiating Effect of GLP-1 [NA]

View source ↗

Summary

A completed clinical trial indicates that achieving near-normal blood glucose levels improves the potentiating effect of GLP-1 in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Diabetes Mellitus Type 2 | NA | Status: COMPLETED